Pharma & Bio
Technology
CoreLineSoft Sets Another Record for German Contracts in May… “Entering a Phase of Recurring Revenue Driven by National Screening Programs”
#CoreLineSoft is rapidly expanding its contracts with local hospitals following the launch of Germany’s national lung cancer screening program. CoreLineSoft, which signed 10 new hospital contracts in …
Lifestyle
'A Comeback for a Treatment Once Thought to Have Failed'… GoBioLab Identifies Key Switch for Psoriasis
“Psoriasis may appear to be a skin condition, but it is actually a systemic inflammatory disease caused by an immune system disorder. We have confirmed that regulating gut microbiota can reduce skin i…
Lifestyle
AriBio and FirstBio Join Lilly’s AI Ecosystem... What Are the Real Benefits?
Korean biotech companies AriBio and First BioTherapeutics have successively joined TuneLab, the artificial intelligence (AI)-based new drug development platform of global pharmaceutical company Eli Li…
Business·Industry
'Armed with 240 billion won in funding,' Olix Pharmaceuticals, Inc. accelerates development of a new short-interference RNA drug for conditions other than liver disease
A chill is settling over the KOSDAQ biotech market. Even companies that were once highlighted as leading new drug developers have faced stock price corrections. In the stock market, there are concerns…
KOSDAQ
Biotech Sector Rises, Led by Hair Loss Stocks… JW New Drug Rises; D&D Pharmatech, Partnering with LG, Also Gains Attention [Bio Spotlight]
On the 17th, the domestic pharmaceutical and biotech sector saw related stocks rally across the board following news that the government is considering expanding health insurance coverage for hair los…
KOSDAQ
Hair-Loss Stocks Lead Biotech Rally...JW Shinyak Hits Daily Limit Up, D&D Pharmatech Gains on LG Partnership [K-Bio Pulse]
South Korea’s pharmaceutical and biotechnology sector saw broad gains on Aug. 17 as stocks related to hair loss treatments surged following news that the government is reviewing the expansion of Natio…
Lifestyle
WiseBirds Leads the Way in Direct Sales of K-Bio Products to North America... ‘Support for a Second Zimpentra’
#WiseBirds, a comprehensive digital marketing firm, has stepped in as a “rescue pitcher” for South Korean pharmaceutical, biotech, and medical device (hereinafter “bio”) companies looking to export to…
Technology
Orum Therapeutics Establishes a Base in Shanghai… Sets Out to Identify ADC Technologies in China
#Orum Therapeutics, a developer of targeted protein degradation (TPD)-based antibody-degradator conjugates (DACs), is establishing a base of operations in Shanghai, China.On the surface, this move is …
Lifestyle
Selbion: Will It Become the Creator of ‘Korea’s 44th New Drug’?... Second Half to Be a Turning Point for Conditional Approval
Market attention is focused on whether #Cellion, regarded as a pioneer in the domestic radiopharmaceutical (RPT) market, will make history with a new domestically developed drug. Recently, #Curocell’s…
Technology
'JLK's Japanese Subsidiary Begins Full Operations'... Global Earnings Set for Quantum Leap
#JLK, South Korea’s first publicly listed medical artificial intelligence (AI) company, has entered the monetization phase in the Japanese market.Having obtained a direct sales license through its Jap…